What is the ideal soil-grass combination for maximum photosynthesis? In this study, we investigated how soil and grassland types affect photosynthesis in the grasslands of Gannan, China. We divided the grasslands of Gannan into 166 study sites, each with a unique soil-grass combination by intersecting the soil and ecoregion maps using ArcGIS. We obtained 19 years of data on the Net Photosynthesis (PsnNet) of grasslands in the area from 2000 to 2018 and then divided them into “growing season” (June to September) and “non-growing season” (October top May). Between 2000 and 2018, PsnNet of grasslands showed a gradually increasing trend. The effect of soil type on PsnNet was not significant during the growing season. However, it was highly significant during the non-growing season. Among the soil types, grasses that grew in Mollic, Gelic, and Haplic soils had the highest rate of photosynthesis. The difference in PsnNet among the various grass types was highly significant during both seasons. However, Tropical and Subtropical succulent evergreen broad-leaf shrubs and Temperate meadows had the highest rate of photosynthesis. Additionally, there was a highly significant difference in PsnNet among the various soil-grass interactions. In the growing season, TStEgBLS growing Eutric soils had the highest PsnNet. However, SaDBLS growing in Gelic soils had the the highest.

In order to study the hydrothermal behavior of cotton fiber, the carbonization process and structural evolution of discarded cotton fiber (WCF) under hydrothermal conditions were discussed use microcrystalline cellulose (MCC) and glucose as model compounds. The results showed that high temperature was beneficial to the hydrolysis of discarded cotton fiber, and the yield of the sugar was 4.5% which was lower than that of MCC 6.51%. WFC and MCC are carbonized in 240~260 ℃ and 220~240 ℃ respectively, while the carbonation temperature of glucose is lower than 220 ℃. The quality ratio of C/O in WCF and glucose hydrothermal products is 5.79 and 5.85 respectively; three kinds of hydrothermal carbonization products have similar crystal structure and oxygen-containing functional groups, and the WCF carbonization products contain a lot of irregular particles while the main products of glucose carbonization are 0.5 μm carbon microspheres (CMCC). The results show that glucose is an important intermediate product of WCF hydrolysis carbonation, and there are two main paths of cotton fiber hydrothermal carbonization: some cotton fibers are completely hydrolyzed into glucose and the nucleation is formed, and then the carbon microspheres are grown; for the other part, the glucose ring of the polysaccharide oligosaccharide formed by the incomplete hydrolysis of cotton fiber in the hydrothermal environment of high temperature and pressure breaks, then forms the particulate matters.

Puerarin (PUE) is a compound isolated from the roots of Pueraria lobata. We studied the pharmacokinetics and tissue distribution kinetics of PUE in Sprague-Dawley rats following intraperitoneal administration of three concentrations. Indirect competitive ELISA based on an anti-PUE monoclonal antibody was used to determine the concentration of PUE in the blood, heart, liver, spleen, lung, kidney, hippocampus, cerebral cortex, and striatum. The plasma and tissue distribution kinetic characteristics following a single injection of PUE (20, 40, and 80 mg/kg) were calculated using a non-compartment model. In the high-dose (80 mg/kg) and medium-dose (40 mg/kg) groups, the kinetic profile of PUE in blood and kidney samples showed two absorption peaks, while that of the other tissues showed only one peak. In the low-dose (20 mg/kg) group, there was only one peak, irrespective of the sample type. Pharmacokinetic parameters such as the area under the curve, C_max, and T_max varied according to the administered dose. AUC and C_max values increased dose-dependently. PUE was widely distributed in areas of the brain such as the hippocampus, cerebral cortex, and striatum, providing a foundation for guiding the use of PUE in the treatment of cerebral ischaemic stroke and neurodegenerative diseases.